Search results
Editas (EDIT) Reports Upbeat New Data From Reni-Cel Studies
Zacks via Yahoo News· 1 month agoEditas (EDIT) reports positive new safety and efficacy data from the RUBY and EdiTHAL studies...
Intellia (NTLA) Banks on Genome Editing Pipeline Amid Rivalry
Zacks via Yahoo News· 1 month agoIntellia's (NTLA) lead genome-editing candidate, NTLA-2001 being developed to treat transthyretin...
Editas (EDIT) Down 2.3% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo News· 1 month agoIt has been about a month since the last earnings report for Editas Medicine (EDIT). Shares have...
Editas (EDIT) Q1 Earnings & Revenues Lag Estimates, Stock Down
Zacks via Yahoo News· 2 months agoEditas Medicine, Inc. EDIT incurred a loss of 76 cents per share in the first quarter of 2024, wider...
Editas Medicine (EDIT) Reports Q1 Loss, Misses Revenue Estimates
Zacks via Yahoo News· 2 months agoEditas (EDIT) delivered earnings and revenue surprises of -20.63% and 90.26%, respectively, for the...
The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
Zacks via Yahoo News· 3 months agoFor Immediate Release Chicago, IL – May 3, 2024 – Zacks.com announces the list of stocks featured in...
Will Editas Medicine (EDIT) Report Negative Q1 Earnings? What You Should Know
Zacks via Yahoo News· 3 months agoEditas (EDIT) doesn't possess the right combination of the two key ingredients for a likely earnings...
Bausch (BHC) Q4 Earnings and Revenues Top Estimates
Zacks via Yahoo News· 5 months agoBausch Health Companies Inc.'s BHC fourth-quarter results were better than expected. The company’s adjusted earnings per share of $1.15 beat the Zacks...
Bayer (BAYRY) Intends to Slash Dividends Amid Challenges
Zacks via Yahoo News· 5 months agoBayer (BAYRY) announced plans to cut dividends to pay out only the legally required minimum for...
Wall Street Analysts Believe Editas (EDIT) Could Rally 80%: Here's is How to Trade
Zacks via Yahoo News· 5 months agoThe average of price targets set by Wall Street analysts indicates a potential upside of 80% in...